Skip to main content
SpringerLink
Log in

Signaling by extracellular nucleotides and nucleosides

  • Editorial
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475

    Google Scholar 

  • Anderson CM, Parkinson FE (1997) Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides. Trends Pharmacol Sci 18:387-392

    Google Scholar 

  • Barnard EA, Simon J, Webb TE (1997) Nucleotide receptors in the nervous system: an abundant component using diverse transduction mechanisms. Mol Neurobiol 15:103-129

    Google Scholar 

  • Deckert J, Gleiter CH (1994) Adenosine - an endogenous neuroprotective metabolite and neuromodulator. J Neural Transm [Suppl] 43:23-31

    Google Scholar 

  • Deussen A (2000) Metabolic flux rates of adenosine in the heart. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000318

  • Di Virgilio F, Sanz JM, Chiozzi P, Falzoni S (1999) The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res 120:356-368

    Google Scholar 

  • Drury AN, Szent-Györgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213-237

    Google Scholar 

  • Dubyak GR, El-Moatassim C (1993) Signal transduction via P2- purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 34:C577-C606

    Google Scholar 

  • Engler RL, Gruber HE (1992) Adenosine: an autacoid. In: Fozzard HA, Haber E, Jennings R, Katz A, Morgan H (eds) The heart and cardiovascular system, 2nd edn. Raven, New York, pp 1745-1764

  • Fabre J-E, Nguyen MT, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199-1202

    Google Scholar 

  • Feoktistov I, Polosa R, Holgate ST, Biaggioni I (1998) Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148-153

    Google Scholar 

  • Filippov AK, Webb TE, Barnard EA, Brown DA (1998) P2Y2 nucleotide receptors expressed heterologously in sympathetic neurons inhibit both N-type Ca2+ and M-type K+ currents. J Neurosci 18:5170-5179

    Google Scholar 

  • Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133

    Google Scholar 

  • Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wassermann W (2000) Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000313

  • Guthrie PB, Knappenberger J, Segal M, Bennett MVL, Charles AC, Kater SB (1999) ATP release from astrocytes mediates glial calcium waves. J Neurosci 19:520-528

    Google Scholar 

  • Haas HL, Selbach O (2000) Functions of neuronal adenosine receptors. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000314

  • Jacobson KA, Kim HO, Siddiqi SM, Olah ME, Stiles GL, Lubitz DKJE von (1995) A3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699

    Google Scholar 

  • Klotz K-N (2000) Adenosine receptors and their ligands. Naunyn- Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/ s002100000315

  • Klotz K-N, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg’s Arch Pharmacol 357:1-9

    Google Scholar 

  • Kügelgen I von, Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324

    Google Scholar 

  • Kügelgen I von, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000310

  • Lambrecht G (2000) Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.

  • Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000312

  • MacKenzie AB, Surprenant A, North RA (1999) Functional and molecular diversity of purinergic ion channel receptors. Ann NY Acad Sci 868:716-729

    Google Scholar 

  • Müller CE, Stein B (1996) Adenosine receptor antagonists: structure and potential therapeutic applications. Curr Pharm Des 2: 501-530

    Google Scholar 

  • Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckle BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89

    Google Scholar 

  • Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13-Nörenberg W, Illes P (2000) Neuronal P2X receptors: localisation and functional properties. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000311

  • Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70:761-845

    Google Scholar 

  • Poulsen S-A, Quinn RJ (1998) Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 6:619-641

    Google Scholar 

  • Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492

    Google Scholar 

  • Richardson PJ, Kase H, Jenner PG (1997) Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson’s disease. Trends Pharmacol Sci 18:338-344

    Google Scholar 

  • Sugita M, Yue Y, Foskett JK (1998) CFTR Cl-channel and CFTRassociated ATP channel: distinct pores regulated by common gates. EMBO J 17:898-908

    Google Scholar 

  • Vulchanova L, Riedl MS, Shuster SJ, Stone LS, Hargreaves KM, Buell G, Surprenant A, North RA, Elde R (1998) P2X3 is expressed by DG neurons that terminate in inner lamina II. Eur J Neurosci 10:3470-3478

    Google Scholar 

  • Zimmermann H (2000) Extracellular hydrolysis of ATP and other nucleotides. Naunyn-Schmiedeberg’s Arch Pharmacol (this issue). DOI 10.1007/s002100000309

  • Zimmermann H, Braun N (1999) Ecto-nucleotidases - molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 120:371-385

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Härtelstrasse 16-18, D-04107, Leipzig, Germany

    P. Illes

  2. Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078, Würzburg, Germany

    K.-N. Klotz & M. J. Lohse

Authors
  1. P. Illes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.-N. Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. J. Lohse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Illes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Illes, P., Klotz, KN. & Lohse, M.J. Signaling by extracellular nucleotides and nucleosides. Naunyn-Schmied Arch Pharmacol 362, 295–298 (2000). https://doi.org/10.1007/s002100000308

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002100000308

Search

Navigation